A group sequential approach to crossover trials for average bioequivalence
From MaRDI portal
Publication:4239500
DOI10.1080/10543409708835171zbMath1063.62593OpenAlexW2007723603WikidataQ52273969 ScholiaQ52273969MaRDI QIDQ4239500
Peter Preston, Frédéric Y. Bois, W. W. Hauck
Publication date: 1997
Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/10543409708835171
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical analysis (62L10)
Related Items (3)
Fixed-width confidence interval of log odds ratio in correlated setup for crossover design ⋮ Group sequential crossover trial designs with strong control of the familywise error rate ⋮ A Confidence Interval That Is Consistent and More Informative Than a Sequential Equivalence Test for a Normal Mean
Cites Work
- Point Estimation Following Group Sequential Tests
- Discrete Sequential Boundaries for Clinical Trials
- Exact confidence intervals following a group sequential trial: A comparison of methods
- Sequential Equivalence Testing and Repeated Confidence Intervals, with Applications to Normal and Binary Responses
- Planning and Monitoring of Equivalence Studies
This page was built for publication: A group sequential approach to crossover trials for average bioequivalence